Advertisement

The Latest

The new CMS pre-reimbursement review program being launched in 11 states next month will target unnecessary medical technology and devices in 15 procedures, according to a MassDevice report.

The FDA found a lack of proper procedures to guarantee drug sterility and correct composition and inadequate cleaning at three Novartis plants, according to a Reuter's report.

Advertisement